Abstract
KSHV is the etiologic agent of PEL-an aggressive lymphoma. Interestingly, EBV concurrently exists in nearly 70% of PEL cases. In this issue of Cell Host & Microbe, McHugh et al. (2017) develop humanized mouse models for EBV/KSHV co-infection and identify their complementary effect on in vivo tumor formation.
Copyright © 2017 Elsevier Inc. All rights reserved.
MeSH terms
-
Animals
-
Coinfection*
-
Disease Models, Animal
-
Epstein-Barr Virus Infections / virology
-
Gene Expression Regulation, Viral
-
HIV / pathogenicity
-
HIV Infections / virology
-
Herpesviridae / pathogenicity*
-
Herpesviridae Infections / virology
-
Herpesvirus 4, Human / pathogenicity
-
Herpesvirus 8, Human / pathogenicity*
-
Humans
-
Lymphoma / virology
-
Lymphoma, Primary Effusion / virology
-
Mice
-
Sarcoma, Kaposi / virology